Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Orth

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Brain Communications|March 7, 2024
Modification of Huntington's disease by short tandem repeatsEun Pyo Hong, Eliana Marisa Ramos, N Ahmad Aziz, et al.
Frontiers in Oncology|December 6, 2021
PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic OutlookMaximilian A Kirchner, Adrien Holzgreve, Matthias Brendel, et al.
Gastroenterology|June 7, 2021
Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma ModelsUjjwal M Mahajan, Qi Li, Ahmed Alnatsha, et al.
Biomedicines|January 23, 2024
The Traumatic Inoculation Process Affects TSPO Radioligand Uptake in Experimental Orthotopic GlioblastomaLukas Gold, Enio Barci, Matthias Brendel, et al.
Endocrinology|July 20, 2019
Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor CulturesMaria Fankhauser, Nicole Bechmann, Michael Lauseker, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|September 5, 2021
Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementiaVincenzo Di Lazzaro, Rita Bella, Alberto Benussi, et al.
Science Translational Medicine|June 12, 2020
Autism-associated SHANK3 mutations impair maturation of neuromuscular junctions and striated musclesAnne-Kathrin Lutz, Stefanie Pfaender, Berra Incearap, et al.
British Journal of Clinical Pharmacology|September 17, 2014
An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's diseaseSigurd D Süssmuth, Salman Haider, G Bernhard Landwehrmeyer, et al.
American Journal of Human Genetics|March 24, 2022
Genetic modifiers of Huntington disease differentially influence motor and cognitive domainsJong-Min Lee, Yuan Huang, Michael Orth, et al.
Biological Psychiatry|February 24, 2020
Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's DiseaseNatalie Ellis, Amelia Tee, Branduff McAllister, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Brain Communications|March 7, 2024
Modification of Huntington's disease by short tandem repeatsEun Pyo Hong, Eliana Marisa Ramos, N Ahmad Aziz, et al.
Frontiers in Oncology|December 6, 2021
PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic OutlookMaximilian A Kirchner, Adrien Holzgreve, Matthias Brendel, et al.
Gastroenterology|June 7, 2021
Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma ModelsUjjwal M Mahajan, Qi Li, Ahmed Alnatsha, et al.
Biomedicines|January 23, 2024
The Traumatic Inoculation Process Affects TSPO Radioligand Uptake in Experimental Orthotopic GlioblastomaLukas Gold, Enio Barci, Matthias Brendel, et al.
Endocrinology|July 20, 2019
Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor CulturesMaria Fankhauser, Nicole Bechmann, Michael Lauseker, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|September 5, 2021
Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementiaVincenzo Di Lazzaro, Rita Bella, Alberto Benussi, et al.
Science Translational Medicine|June 12, 2020
Autism-associated SHANK3 mutations impair maturation of neuromuscular junctions and striated musclesAnne-Kathrin Lutz, Stefanie Pfaender, Berra Incearap, et al.
British Journal of Clinical Pharmacology|September 17, 2014
An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's diseaseSigurd D Süssmuth, Salman Haider, G Bernhard Landwehrmeyer, et al.
American Journal of Human Genetics|March 24, 2022
Genetic modifiers of Huntington disease differentially influence motor and cognitive domainsJong-Min Lee, Yuan Huang, Michael Orth, et al.
Biological Psychiatry|February 24, 2020
Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's DiseaseNatalie Ellis, Amelia Tee, Branduff McAllister, et al.
Pageof 15